Press "Enter" to skip to content

Prof. Dr. Missed Özkan explained: A patient with mutation was detected in Antalya


Sinovac vaccine testing companies to voluntarily join the corona virus vaccine among the first who checks in Turkey Akdeniz University (AU) Rector Prof. Dr. Ozkanexplained that a very high level of antibody was seen in his body about 1 month after the first dose.

Stating that the antibody level varies from person to person, Prof. Dr. Özkan explained that the antibodies produced are the soldiers of the body and that they emerge due to the body’s immune system. Stating that the current values ​​are effective, Prof. Dr. Özkan explained the latest situation in vaccination at Akdeniz University.

THE RESULT IS REACHED WITH THE MUTATION DETECTION KIT

Prof. Dr. Özkan announced that 4,700 people have been vaccinated since they started vaccination studies as AU. Stating that they will start the second dose of vaccination on Thursday, Prof. Dr. Özkan made statements regarding the mutation of the corona virus.

Prof. Dr. Özkan Özkan said, “There are several different mutations such as South Africa and England defined so far. You can also look at the mutations with kits. After the mutation kits we received, a UK mutation appeared in one of our patients. “Which of a few types of vaccines is most effective and how long this effect lasts will be revealed as a result of the follow-up. The important thing is how it will change the treatments. We cannot respond to these immediately, but we will try to observe and understand with publications over time.”

” MUTATION WILL CONTINUE ”

Explaining the treatment applied to the patient who caught the mutation of the Corona virus in England, Prof. Dr. Özlen Özkan said, “There is no different treatment at the moment. It does not progress clinically very differently. However, this mutation will continue to be, it will not stay that way. It is necessary to see where the result has evolved after the mutation. It seems that the treatments do not require much difference at the moment,” he said.

Commenting on the news that the vaccine developed by Oxford University and AstraZeneca was ineffective against the mutated virus, Prof. Dr. Özkan said, “This is not very good news. This was the thing we feared the most. Because we have the only weapon against the corona virus. If we have such information, we will try to find vaccines for mutation. Sinovac vaccine is an inactive vaccine, I think this vaccine. “It feels like it will be less affected by the mutation. We will see this over time,” he said.

THE MINISTRY OF HEALTH IS FOLLOWING THE VACCINATION STUDY AT AU

Providing the latest information about the vaccine study conducted at AU, Prof. Dr. Özkan said, “Prof. Dr. Tarlan Mammedov achieved the protein target. This is a vaccine study followed by the Ministry of Health. However, it is necessary to look at how effective the mutant virus is. We are working not only on vaccines, but also on kits and drugs. “How effective it will be and how quickly we will release it to the market. All of these require separate financial support.”

VIDEO: DOES THE HAPPY VIRUS EXCEED THE MASK?


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *